A detailed history of Neos Investment Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 14,884 shares of BIIB stock, worth $2.22 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
14,884
Previous 12,991 14.57%
Holding current value
$2.22 Million
Previous $3.01 Billion 4.2%
% of portfolio
0.09%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$189.07 - $236.8 $357,909 - $448,262
1,893 Added 14.57%
14,884 $2.89 Billion
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $617,856 - $767,682
3,243 Added 33.27%
12,991 $3.01 Billion
Q1 2024

May 13, 2024

BUY
$212.02 - $267.71 $617,190 - $779,303
2,911 Added 42.58%
9,748 $2.1 Billion
Q4 2023

Feb 13, 2024

BUY
$222.59 - $267.94 $78,574 - $94,582
353 Added 5.44%
6,837 $1.77 Billion
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $1.64 Million - $1.85 Million
6,484 New
6,484 $1.67 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.